210 related articles for article (PubMed ID: 24380930)
1. Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches.
Marballi KK; McCullumsmith RE; Yates S; Escamilla MA; Leach RJ; Raventos H; Walss-Bass C
J Neural Transm (Vienna); 2014 May; 121(5):479-90. PubMed ID: 24380930
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
[TBL] [Abstract][Full Text] [Related]
3. A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia.
Walss-Bass C; Liu W; Lew DF; Villegas R; Montero P; Dassori A; Leach RJ; Almasy L; Escamilla M; Raventos H
Biol Psychiatry; 2006 Sep; 60(6):548-53. PubMed ID: 16730337
[TBL] [Abstract][Full Text] [Related]
4. Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats.
Nawwar DA; Zaki HF; Sayed RH
Inflammopharmacology; 2022 Oct; 30(5):1891-1907. PubMed ID: 35876932
[TBL] [Abstract][Full Text] [Related]
5. A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice.
Newell KA; Karl T; Huang XF
Neuroscience; 2013 Sep; 248():670-80. PubMed ID: 23811072
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain.
Deng C; Pan B; Hu CH; Han M; Huang XF
Psychiatry Res; 2015 Feb; 225(3):347-54. PubMed ID: 25576368
[TBL] [Abstract][Full Text] [Related]
7. Increased NRG1-ErbB4 signaling in human symptomatic epilepsy.
Zhu JM; Li KX; Cao SX; Chen XJ; Shen CJ; Zhang Y; Geng HY; Chen BQ; Lian H; Zhang JM; Li XM
Sci Rep; 2017 Mar; 7(1):141. PubMed ID: 28273943
[TBL] [Abstract][Full Text] [Related]
8. Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
Papaleo F; Yang F; Paterson C; Palumbo S; Carr GV; Wang Y; Floyd K; Huang W; Thomas CJ; Chen J; Weinberger DR; Law AJ
J Neurosci; 2016 Apr; 36(17):4859-75. PubMed ID: 27122041
[TBL] [Abstract][Full Text] [Related]
9. Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration.
Haskins JW; Nguyen DX; Stern DF
Sci Signal; 2014 Dec; 7(355):ra116. PubMed ID: 25492965
[TBL] [Abstract][Full Text] [Related]
10. Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.
Nicodemus KK; Law AJ; Radulescu E; Luna A; Kolachana B; Vakkalanka R; Rujescu D; Giegling I; Straub RE; McGee K; Gold B; Dean M; Muglia P; Callicott JH; Tan HY; Weinberger DR
Arch Gen Psychiatry; 2010 Oct; 67(10):991-1001. PubMed ID: 20921115
[TBL] [Abstract][Full Text] [Related]
11. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.
Norton N; Moskvina V; Morris DW; Bray NJ; Zammit S; Williams NM; Williams HJ; Preece AC; Dwyer S; Wilkinson JC; Spurlock G; Kirov G; Buckland P; Waddington JL; Gill M; Corvin AP; Owen MJ; O'Donovan MC
Am J Med Genet B Neuropsychiatr Genet; 2006 Jan; 141B(1):96-101. PubMed ID: 16249994
[TBL] [Abstract][Full Text] [Related]
12. Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome.
Banerjee A; Macdonald ML; Borgmann-Winter KE; Hahn CG
Brain Res Bull; 2010 Sep; 83(3-4):132-9. PubMed ID: 20433909
[TBL] [Abstract][Full Text] [Related]
13. Effects of prolonged antipsychotic administration on neuregulin-1/ErbB signaling in rat prefrontal cortex and myocardium: implications for the therapeutic action and cardiac adverse effect.
Dang R; Guo Y; Cai H; Yang R; Liang D; Lv C; Jiang P
J Toxicol Sci; 2016 Apr; 41(2):303-9. PubMed ID: 26961615
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated stabilization of NRG1 induces behavioral and electrophysiological alterations in adult mice.
Dominguez SL; Hegde GV; Hanson JE; Xiang H; Mandikian D; Boswell CA; Chiu C; Wu Y; Tsai SP; Fleck D; Weber M; Ngu H; Scearce-Levie K; Jackson EL
Sci Rep; 2018 May; 8(1):8239. PubMed ID: 29844389
[TBL] [Abstract][Full Text] [Related]
15. Down-Regulation of Neuregulin1/ErbB4 Signaling in the Hippocampus Is Critical for Learning and Memory.
Tian J; Geng F; Gao F; Chen YH; Liu JH; Wu JL; Lan YJ; Zeng YN; Li XW; Yang JM; Gao TM
Mol Neurobiol; 2017 Aug; 54(6):3976-3987. PubMed ID: 27295274
[TBL] [Abstract][Full Text] [Related]
16. ErbB4 Mutation that Decreased NRG1-ErbB4 Signaling Involved in the Pathogenesis of Amyotrophic Lateral Sclerosis/Frontotemporal Dementia.
Sun L; Cheng B; Zhou Y; Fan Y; Li W; Qiu Q; Fang Y; Xiao S; Zheng H; Li X
J Alzheimers Dis; 2020; 74(2):535-544. PubMed ID: 32065797
[TBL] [Abstract][Full Text] [Related]
17. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.
Pitcher GM; Kalia LV; Ng D; Goodfellow NM; Yee KT; Lambe EK; Salter MW
Nat Med; 2011 Apr; 17(4):470-8. PubMed ID: 21441918
[TBL] [Abstract][Full Text] [Related]
18. The ERBB4 intracellular domain (4ICD) regulates NRG1-induced gene expression in hippocampal neurons.
Allison JG; Das PM; Ma J; Inglis FM; Jones FE
Neurosci Res; 2011 Jun; 70(2):155-63. PubMed ID: 21352860
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.
Deng C; Pan B; Engel M; Huang XF
Psychopharmacology (Berl); 2013 Mar; 226(2):201-15. PubMed ID: 23389757
[TBL] [Abstract][Full Text] [Related]
20. Calcyon stimulates neuregulin 1 maturation and signaling.
Yin DM; Chen YJ; Liu S; Jiao H; Shen C; Sathyamurthy A; Lin TW; Xiong WC; Li BM; Mei L; Bergson C
Mol Psychiatry; 2015 Oct; 20(10):1251-60. PubMed ID: 25349163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
